Trifluoroacetic acid → HCID 59605562, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([C:14]([C:17]2[N:18]([CH3:43])[C:19]3[C:24]([N:25]=2)=[C:23]([N:26]2[CH2:31][CH2:30][O:29][CH2:28][CH2:27]2)[N:22]=[C:21]([N:32]2[C:36]4[CH:37]=[CH:38][CH:39]=[CH:40][C:35]=4[N:34]=[C:33]2[CH2:41][CH3:42])[N:20]=3)([OH:16])[CH3:15])[CH2:10][CH2:9]1)=O)(C)(C)C.C(O)(C(F)(F)F)=O>C(Cl)Cl>[CH2:41]([C:33]1[N:32]([C:21]2[N:20]=[C:19]3[C:24]([N:25]=[C:17]([C:14]([CH:11]4[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]4)([OH:16])[CH3:15])[N:18]3[CH3:43])=[C:23]([N:26]3[CH2:31][CH2:30][O:29][CH2:28][CH2:27]3)[N:22]=2)[C:36]2[CH:37]=[CH:38][CH:39]=[CH:40][C:35]=2[N:34]=1)[CH3:42]Participants
4
Procedure
To a solution of 4-{1-[2-(2-ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purin-8-yl]-1-hydroxyethyl}piperidine-1-carboxylic acid tert-butyl ester (104 mg, 0.18 mmol) in DCM (1 mL) was added TFA (1 mL) and the resulting mixture stirred for 1 h. The reaction mixture was concentrated in vacuo and azeotroped with DCM affording 1-[2-(2-Ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purin-8-yl]-1-piperidin-4-ylethanol. LCMS (method A): RT 1.88 min, [M+H]+ 491.2
Workup
- concentrationThe reaction mixture was concentrated in vacuo
- customazeotroped with DCM
Sources & evidence
- ORD record
- ord-81ed1241bcae401fa6839ea414c6f4c4
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08173650B2
Reaction notes
Loading…